Clear cell cancer treatment breakthrough reveals how pembrolizumab + lenvatinib is reshaping rare cancer care—and exposing systemic gaps. Clear Cell Cancer Treatment Breakthrough: Why This “Promising Trial” Signals a Much Bigger Shift